Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Q
Qaddoumi, Mohammad
Kuwait University
(
T1230-04-22
)
Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Mohammad Qaddoumi
Favorite
Qian, Jie
Resolian
(
W1030-06-32
)
An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Jie Qian
Favorite
Qi, Luqing
Dow Chemical Company
(
M1230-07-38
)
Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Luqing Qi
Favorite
Qin, Bin
US Food and Drug Administration
(
M1030-01-03
)
Reverse Engineering of Nexplanon
®
Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Bin Qin
Favorite
(
M1430-01-03
)
Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Bin Qin
Favorite
(
T0930-03-17
)
Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Bin Qin
Favorite
(
T1330-09-49
)
In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Bin Qin
Favorite
(
T1530-09-49
)
Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Bin Qin
Favorite
(
W1130-11-64
)
Reverse Engineering of the Sublocade
®
Buprenorphine In Situ Forming Implant
Bin Qin
Favorite
Qi, Qingqing
BeiGene (Beijing) Ltd., Co.
(
T0930-10-54
)
Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Qingqing Qi
Favorite
Qiu, Yihong
QPD Solutions LLC.
(
W1230-01-01
)
Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Yihong Qiu
Favorite
Qi, Wenzhu
Purdue University
(
T1230-10-56
)
Nanosac Formulation for Nucleic Acid Delivery to the Brain
Wenzhu Qi
Favorite
Quadros, Mural
St. John's University
(
W1130-01-06
)
DoE-Enabled Development of Osimertinib-Encapsulated PLGA Nanoparticles for the Treatment of Non-Small Cell Lung Cancer
Mural Quadros
Favorite
Quadry, Zahara
Patheon, part of Thermo Fisher Scientific
(
M1230-07-40
)
Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Zahara Quadry
Favorite
Qu, Li
WuXi AppTec
(
M1030-06-36
)
Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Li Qu
Favorite
(
W1030-06-36
)
Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Li Qu
Favorite
